BRBS vs. ARKG

Last updated Jul 18, 2026

BRBS (Blue Ridge Bankshares, Inc.) is a stock, while ARKG (ARK Genomic Revolution Multi-Sector ETF) is Health & Biotech Equities fund actively managed by ARK. Over the past 10 years, BRBS returned -5.00%/yr vs 9.10%/yr for ARKG. At a 0.17 correlation, their price movements are largely independent.

Performance

BRBS vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Blue Ridge Bankshares, Inc. (BRBS) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BRBS achieves a -5.39% return, which is significantly lower than ARKG's 37.63% return. Over the past 10 years, BRBS has underperformed ARKG with an annualized return of -5.00%, while ARKG has yielded a comparatively higher 9.10% annualized return.

BRBS

• 1D: -2.54%
• 1M: 4.53%
• 6M: -6.27%
• YTD: -5.39%
• 1Y: 7.54%
• 3Y*: -21.33%
• 5Y*: -23.65%
• 10Y*: -5.00%

ARKG

• 1D: -0.55%
• 1M: 13.78%
• 6M: 25.30%
• YTD: 37.63%
• 1Y: 62.80%
• 3Y*: 1.83%
• 5Y*: -13.51%
• 10Y*: 9.10%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BRBS vs. ARKG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BRBS Blue Ridge Bankshares, Inc.	-5.39%	40.14%	6.27%	-75.19%	-27.87%	55.01%	-12.56%	24.18%	4.45%	14.52%
ARKG ARK Genomic Revolution Multi-Sector ETF	37.63%	23.04%	-28.24%	16.22%	-53.90%	-33.92%	180.40%	44.00%	-1.26%	46.61%

Correlation

The correlation between BRBS and ARKG is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.28
Correlation (5Y) Calculated over the trailing 5-year period	0.29
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014	0.17

The correlation between BRBS and ARKG shifts across timeframes, from 0.12 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

BRBS vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRBS

BRBS Risk / Return Rank: 53
BRBS Sharpe Ratio Rank: 56
BRBS Sortino Ratio Rank: 48
BRBS Omega Ratio Rank: 48
BRBS Calmar Ratio Rank: 56
BRBS Martin Ratio Rank: 56

ARKG

ARKG Risk / Return Rank: 52
ARKG Sharpe Ratio Rank: 54
ARKG Sortino Ratio Rank: 57
ARKG Omega Ratio Rank: 48
ARKG Calmar Ratio Rank: 58
ARKG Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BRBS vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Blue Ridge Bankshares, Inc. (BRBS) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BRBS	ARKG	Difference
Sharpe ratio: Return per unit of total volatility	0.28	1.47	-1.19
Sortino ratio: Return per unit of downside risk	0.58	2.17	-1.59
Omega ratio: Gain probability vs. loss probability	1.07	1.25	-0.17
Calmar ratio: Return relative to maximum drawdown	0.43	2.29	-1.87
Martin ratio: Return relative to average drawdown	0.82	5.45	-4.63

BRBS vs. ARKG - Sharpe Ratio Comparison

The current BRBS Sharpe Ratio is 0.28, which is lower than the ARKG Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of BRBS and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BRBS vs. ARKG - Drawdown Comparison

The maximum BRBS drawdown since its inception was -88.26%, which is greater than ARKG's maximum drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for BRBS and ARKG.

Drawdown Indicators

	BRBS	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-88.26%	-83.59%	-4.67%
Max Drawdown (1Y) Largest decline over 1 year	-17.76%	-27.51%	+9.75%
Max Drawdown (3Y) Largest decline over 3 years	-77.38%	-51.96%	-25.42%
Max Drawdown (5Y) Largest decline over 5 years	-88.26%	-79.26%	-9.00%
Max Drawdown (10Y) Largest decline over 10 years	-88.26%	-83.59%	-4.67%
Current Drawdown Current decline from peak	-76.02%	-64.33%	-11.69%
Average Drawdown Average peak-to-trough decline	-50.96%	-36.17%	-14.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.26%	11.55%	-2.29%

Volatility

BRBS vs. ARKG - Volatility Comparison

The current volatility for Blue Ridge Bankshares, Inc. (BRBS) is 6.89%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.42%. This indicates that BRBS experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BRBS	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.89%	12.42%	-5.53%
Volatility (6M) Calculated over the trailing 6-month period	16.95%	31.43%	-14.48%
Volatility (1Y) Calculated over the trailing 1-year period	27.17%	42.89%	-15.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.22%	46.10%	+0.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.70%	41.39%	+0.31%

Dividends

BRBS vs. ARKG - Dividend Comparison

BRBS's dividend yield for the trailing twelve months is around 24.57%, while ARKG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%	0.00%	0.00%
BRBS Blue Ridge Bankshares, Inc.	24.57%	5.85%	0.00%	8.09%	3.90%	2.43%	2.40%	2.04%	3.13%	1.88%	2.07%	2.83%

Frequently Asked Questions

Can I hold both BRBS and ARKG in my portfolio?

BRBS and ARKG have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BRBS or ARKG?

ARKG has higher volatility (12.42%) compared to BRBS (6.89%). In terms of maximum drawdown, BRBS dropped -88.26% vs ARKG's -83.59%.

Which has better risk-adjusted returns?

ARKG currently has the higher Sharpe Ratio (1.47 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.